Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis

M.A. Willemsen, M.M. Verbeek, E.J. Kamsteeg, J. de Rijk-van Andel, A. Aeby, N. Blau, A. Burlina, M.A. Donati, B. Geurtz, P.J. Grattan-Smith, M. Haeussler, G.F. Hoffmann, H. Jung, J.B. de Klerk, M.S. van der Knaap, F. Kok, V. Leuzzi, P. de Lonlay, A. Megarbane, H. MonaghanW.O. Renier, P. Rondot, M.M. Ryan, J. Seeger, J.A. Smeitink, G.C. Steenbergen-Spanjers, E. Wassmer, B. Weschke, F.A. Wijburg, B. Wilcken, D.I. Zafeiriou, R.A. Wevers

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1810-1822
JournalBrain
Volume133
DOIs
Publication statusPublished - 2010

Cite this

Willemsen, M. A., Verbeek, M. M., Kamsteeg, E. J., de Rijk-van Andel, J., Aeby, A., Blau, N., ... Wevers, R. A. (2010). Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis. Brain, 133, 1810-1822. https://doi.org/10.1093/brain/awq087